Clinical trial
FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
NCT00743925 is registered in ClinicalTrials.gov with Anthera Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
- Lead sponsor
- Anthera Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- April 30, 2010
- Enrollment
- 625 (actual)
- Sites
- 44
Conditions
As the registry lists them; a condition with its own page is linked.